Evolution of the Average Target: UnitedHealth Group Incorporated

Evolution of the Target Price: UnitedHealth Group Incorporated

Changes in Analyst Recommendations: UnitedHealth Group Incorporated

96cc6a1d3c.CWodhqAJYOilYi8PY7NBFH_BERWxSz17D-VQwltP1Rs.ZBxF9vc9AoScCUNWKp4CSxjzPFLnOHcjO6ZmjT57rF5IB3j_6mpRp5EqZg~cf5b77ec12cd9ce9fa7afd95317181b4
07-21 JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating MT
07-21 Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating MT
07-20 Bernstein Adjusts UnitedHealth Price Target to $512 From $492, Maintains Outperform Rating MT
07-20 Argus Adjusts Price Target on UnitedHealth to $470 From $400, Maintains Buy Rating MT
07-17 Leerink Partners Adjusts UnitedHealth Group Price Target to $472 From $462 MT
07-17 UnitedHealth Poised for Further Growth Despite Employer Commercial Pressure, RBC Says MT
07-17 UBS Adjusts Price Target on UnitedHealth to $490 From $460, Maintains Buy Rating MT
07-17 Piper Sandler Adjusts UnitedHealth Price Target to $499 From $477, Maintains Overweight Rating MT
07-17 Oppenheimer Adjusts Price Target on UnitedHealth to $500 From $420, Maintains Outperform Rating MT
07-17 Deutsche Bank Raises UnitedHealth Group Price Target to $467 From $370, Maintains Hold Rating MT
07-17 RBC Capital Adjusts UnitedHealth Price Target to $478 From $463, Maintains Outperform Rating MT
07-17 Morgan Stanley Adjusts Price Target on UnitedHealth to $529 From $468, Maintains Overweight Rating MT
07-17 Truist Raises Price Target on UnitedHealth Group to $500 From $480, Keeps Buy Rating MT
07-17 Jefferies Adjusts Price Target on UnitedHealth to $490 From $401, Maintains Buy Rating MT
07-17 KeyBanc Adjusts Price Target on UnitedHealth to $500 From $475, Maintains Overweight Rating MT
07-17 Barclays Adjusts Price Target on UnitedHealth to $441 From $429, Maintains Overweight Rating MT
07-17 Cantor Fitzgerald Adjusts Price Target on UnitedHealth to $495 From $440, Maintains Overweight Rating MT
07-17 Goldman Sachs Adjusts Price Target on UnitedHealth to $490 From $435, Maintains Buy Rating MT
07-16 UnitedHealth's Strong Q2 Results Set Higher Expectations for H2, Truist Says MT
07-16 Baird Upgrades UnitedHealth Group to Neutral From Underperform, Price Target is $453 MT
07-16 Piper Sandler Adjusts Price Target on UnitedHealth Group to $477 From $475, Maintains Overweight Rating MT
07-16 Piper Sandler Adjusts Price Target on UnitedHealth to $475 From $420, Keeps Overweight Rating MT
07-15 Piper Sandler Raises Price Target on UnitedHealth Group to $475 From $420, Maintains Overweight Rating MT
07-14 Raymond James Adjusts Price Target on UnitedHealth Group to $460 From $370, Maintains Outperform Rating MT
07-14 Truist Raises Price Target on UnitedHealth Group to $480 From $440, Keeps Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.66%
+10.21%
+20.85%
+4.25%
+6.9%
+4.14%
+77.82%
+21.43%
+32.04%
Average +21.92%
Weighted average by Cap. +16.62%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
397.14USD
Average target price
475.23USD
Spread / Average Target
+19.66%
High Price Target
529.00USD
Spread / Highest target
+33.20%
Low Price Target
313.00USD
Spread / Lowest Target
-21.19%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. UNH Stock
  4. UNHH34 Stock
  5. Consensus UnitedHealth Group Incorporated